Alteration of Vascular Responsiveness to Uridine Adenosine Tetraphosphate in Aortas Isolated from Male Diabetic Otsuka Long-Evans Tokushima Fatty Rats: The Involvement of Prostanoids

Int J Mol Sci. 2017 Nov 9;18(11):2378. doi: 10.3390/ijms18112378.

Abstract

We investigated whether responsiveness to dinucleotide uridine adenosine tetraphosphate (Up₄A) was altered in aortas from type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats compared with those from age-matched control Long-Evans Tokushima Otsuka (LETO) rats at the chronic stage of disease. In OLETF aortas, we observed the following: (1) Up₄A-induced contractions were lower than those in the LETO aortas under basal conditions, (2) slight relaxation occurred due to Up₄A, but this was not observed in phenylephrine-precontracted LETO aortas, (3) acetylcholine-induced relaxation was reduced (vs. LETO), and (4) prostanoid release (prostaglandin (PG)F, thromboxane (Tx)A₂ metabolite, and PGE₂) due to Up₄A was decreased (vs. LETO). Endothelial denudation suppressed Up₄A-induced contractions in the LETO group, but increased the contractions in the OLETF group. Under nitric oxide synthase (NOS) inhibition, Up₄A induced contractions in phenylephrine-precontracted aortas; this effect was greater in the LETO group (vs. the OLETF group). The relaxation response induced by Up₄A was unmasked by cyclooxygenase inhibitors, especially in the LETO group, but this effect was abolished by NOS inhibition. These results suggest that the relaxant component of the Up₄A-mediated response was masked by prostanoids in the LETO aortas and that the LETO and OLETF rats presented different contributions of the endothelium to the response.

Keywords: Up4A; aorta; contraction; prostanoid; relaxation; type 2 diabetes.

MeSH terms

  • Acetylcholine / pharmacology
  • Animals
  • Aorta, Thoracic / drug effects*
  • Aorta, Thoracic / metabolism
  • Chronic Disease
  • Cyclooxygenase Inhibitors / pharmacology
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Dinucleoside Phosphates / pharmacology*
  • Disease Models, Animal
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Male
  • Nitric Oxide / antagonists & inhibitors
  • Phenylephrine / pharmacology
  • Prostaglandins / metabolism*
  • Rats
  • Rats, Inbred OLETF

Substances

  • Cyclooxygenase Inhibitors
  • Dinucleoside Phosphates
  • Prostaglandins
  • uridine adenosine tetraphosphate
  • Phenylephrine
  • Nitric Oxide
  • Acetylcholine